The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 21, 2026

20 minutes ago

More South Africans Are Selling Damaged Cars as Repair Costs Continue to Climb

EIN Presswire

an hour ago

NoOnes Confirms Stablecoin Explosion in Africa – Now 60% of All Trades

EIN Presswire

2 hours ago

Chapel Hill Denham’s Philip Southwell Expected to Join Global Trading Championship, Firm Says

EIN Presswire

2 hours ago

Tensões no Médio Oriente trazem desafios para o Agronegócio

EIN Presswire

4 hours ago

CortexForge Marks Year One with Integration as the First Proof

EIN Presswire

9 hours ago

FMUSER Releases Multi-Language Video Guide for Setting Up Hotel IPTV Systems

EIN Presswire

32 minutes ago

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

GlobeNewswire

an hour ago

Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026

GlobeNewswire

an hour ago

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies

GlobeNewswire

2 hours ago

Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

GlobeNewswire

2 hours ago

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

GlobeNewswire

2 hours ago

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

GlobeNewswire

2 hours ago

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution

GlobeNewswire

2 hours ago

Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia

GlobeNewswire

2 hours ago

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

GlobeNewswire

2 hours ago

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

GlobeNewswire

2 hours ago

Critical Metals Corp. (Nasdaq: CRML) Announces Private Placement of Ordinary Shares for Proceeds of $60 Million

GlobeNewswire

3 hours ago

Trident Resources Announces Closing of Purchase of Additional 4,711 Hectares at the Contact Lake Gold and Greywacke Gold Projects

GlobeNewswire

3 hours ago

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

3 hours ago

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

GlobeNewswire